20 Matching Annotations
  1. Last 7 days
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Rapid Discovery of Potent Neutralizing Antibodies against SARS-CoV‑2 through Directed Evolution of SARS-CoV‑1 Antibodies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12406247/
  3. Aug 2025
  4. 52.53.155.43 52.53.155.43
    ssrn-5367706-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/d4ac87e5901810967bc62a763150192c57d079f9/ssrn-5367706-html.html
  5. Jul 2025
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Broad-Spectrum Antiviral Styrene Maleic-Acid Copolymer Lipid Particle Nanodiscs for pH-Responsive Irreversible Virus Inactivation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12264959/
  7. Jun 2025
  8. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Long-Term Dynamics of SARS-CoV-2 Variant-Specific Neutralizing Antibodies Following mRNA Vaccination and Infection
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12115524/
  9. May 2025
  10. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11998512/
  11. Apr 2025
  12. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Serological Assays Reveal No Evidence of Natural SARS-CoV-2 Infection in US Cattle
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11944350/
  13. Mar 2025
  14. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11900932/
  15. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11761773/
  16. Jun 2024
  17. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11197847/
  18. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Generation of nanobodies from transgenic ‘LamaMice’ lacking an endogenous immunoglobulin repertoire
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11148044/
  19. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Development and utility of a SARS-CoV-2 pseudovirus assay for compound screening and antibody neutralization assays
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11141373/
  20. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11142672/
  21. May 2024
  22. www.sciencedirect.com www.sciencedirect.com
    Unraveling the antiviral activity of Stachytarpheta cayennensis against SARS-CoV-2 variants using in vitro and molecular docking analysis
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0254629924002643
  23. Apr 2024
  24. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11053511/
  25. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10973674/
  26. Mar 2024
  27. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10888787/
  28. Sep 2023
  29. www.biorxiv.org www.biorxiv.org
    Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2023.09.19.558444v1
  30. Jan 2023
  31. www.mdpi.com www.mdpi.com
    Inhibitory Activity of Saussurea costus Extract against Bacteria, Candida, Herpes, and SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    mdpi.com/2223-7747/12/3/460
  32. Nov 2022
  33. www.sciencedirect.com www.sciencedirect.com
    Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1931312822005236
  34. Aug 2022
  35. www.sciencedirect.com www.sciencedirect.com
    SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124722011044